Cowen & Company Initiates Coverage on Multiple MSO’s, Gives Medmen $1.50 Price Target
Industry analysts Cowen and Company initiated coverage on several US multiple state operators this morning, putting out a 170 page
Read more
MedMen Enterprises
US Cannabis, Momentum, With Lots of Hurdles
The US Cannabis market has been a confusing ride for investors to comprehend. We have a huge market, that isn’t
Read more
Medmen One Step Closer to Closing PharmaCann Merger
Medmen Enterprises (CSE: MMEN) announced that it is one step closer to closing its acquisition of PharmaCann LLC this morning.
Read more
MedMen Reports Pro-Forma Preliminary Revenue of US$61.3M for Fourth Quarter
MedMen Enterprises (CSE: MMEN) released preliminary financials for the fourth quarter of FY2019, stating system-wide revenues of US$61.3 million for
Read more
MedMen Secures Further Funding From Gotham Green Partners
MedMen Enterprises Inc. (CSE:MMEN) has returned to the trough with Gotham Green Partners as expected, however this time things are
Read more
Is the End of the Line Near for MedMen?
It’s long been known by cannabis industry followers that MedMen Enterprises (CSE: MMEN) has a cash problem. Relentless general and
Read more
#Potstocks Earnings Roundup: May 29
As we alluded to in an article released Monday morning, there were a number of cannabis focused public companies that
Read more